Skip to main content
DVA
NYSE Industrial Applications And Services

DaVita Q2 Earnings Beat, Raises Full-Year EPS Guidance to $14.10-$15.20

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$211.9
Mkt Cap
$14.637B
52W Low
$101
52W High
$247.49
52W Position info
110% above low
Off High info
14% below high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

DVA has more than doubled off its 52-week low of $101 on elevated volume (2.9× avg).

Summary

DaVita reported Q2 2026 earnings that beat expectations, raised full-year EPS guidance above consensus, and continued aggressive share buybacks, signaling strong operational momentum.


Key Events · Earnings and Guidance · DVA

  • Q2 Earnings Beat

    Net income of $265.4M ($4.02 diluted EPS) vs. $199.3M ($2.58) a year ago; revenue rose to $3.554B from $3.380B.

  • Raised Full-Year Guidance

    Adjusted diluted EPS guidance raised to $14.10-$15.20, above consensus; free cash flow guidance increased to $1.0B-$1.25B.

  • Aggressive Share Repurchases

    2.2M shares repurchased in Q2 at avg $154.95; additional 0.2M shares bought post-quarter at avg $199.55, totaling $385M.

  • Debt Refinancing

    Entered $500M incremental Term Loan B-2 in June 2026; proceeds used to repay revolver and for general corporate purposes.


Analysis · DVA · Industrial Applications And Services

DaVita delivered a strong Q2, with net income surging to $265.4 million ($4.02/share) from $199.3 million a year ago, driven by revenue growth and margin expansion. The company raised its full-year adjusted EPS guidance to $14.10-$15.20, above consensus, and boosted free cash flow expectations to $1.0-$1.25 billion. Aggressive share repurchases continued — 2.2 million shares bought in Q2 at an average $154.95, with another 0.2 million shares bought post-quarter near $200. The $500 million incremental term loan refinancing strengthens the balance sheet. Against a backdrop of recent insider selling, these results and the raised outlook signal operational momentum and confidence in capital returns.

At the time of this filing, DVA was trading at $211.90 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $101.00 to $247.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DVA - Latest Insights

DVA
Aug 04, 2026, 4:36 PM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $214.99
Real-time Price: $211.00 info
Change: -$3.99 (-2%) info
Market Cap: $14.637B info
DVA
Aug 04, 2026, 4:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $218.00
Real-time Price: $211.00 info
Change: -$7.00 (-3%) info
Market Cap: $14.637B info
DVA
Jun 17, 2026, 6:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $210.58
Real-time Price: $211.00 info
Change: +$0.420 (+0.20%) info
Market Cap: $14.637B info
DVA
Jun 16, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $208.98
Real-time Price: $211.00 info
Change: +$2.02 (+0.97%) info
Market Cap: $14.637B info
DVA
Jun 08, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $192.08
Real-time Price: $211.00 info
Change: +$18.92 (+10%) info
Market Cap: $14.637B info